Agile Therapeutics Inc. (AGRX)
NASDAQ: AGRX
· Real-Time Price · USD
1.51
0.05 (3.42%)
At close: Aug 22, 2024, 9:58 PM
Agile Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.2 | 0.24 | -0.32 | -2.22 | -0.34 | -0.71 | -0.18 | -0.12 | -0.11 | -0.56 | -0.61 | -1.33 | -1.67 | -2.66 |
PEG Ratio | 0.00 | -0.00 | -0.00 | 0.03 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | -0.05 | 0.14 | -0.97 | 0.89 |
PS Ratio | 1.74 | 0.22 | 1.60 | 1.06 | 0.95 | 2.68 | 2.34 | 3.66 | 2.47 | 14.86 | 37.62 | 69.57 | 99.54 | 1.57K |
PB Ratio | -0.44 | -0.12 | -0.35 | -0.57 | -0.43 | -1.08 | -1.69 | 1.76 | 1.54 | 9.54 | 6.14 | 8.38 | 4.79 | 5.20 |
P/FCF Ratio | 41.64 | -0.51 | 33.60 | 19.40 | -0.61 | -6.4 | -5.98 | -0.65 | -1.79 | -1.76 | -3.42 | -4.8 | -7.65 | -12.37 |
P/OCF Ratio | 41.64 | -0.51 | 33.60 | 19.40 | -0.61 | -6.4 | -6 | -0.66 | -1.79 | -1.77 | -3.43 | -4.82 | -7.69 | -12.43 |
OCF/S Ratio | 0.04 | -0.43 | 0.05 | 0.05 | -1.55 | -0.42 | -0.39 | -5.56 | -1.38 | -8.38 | -10.98 | -14.44 | -12.94 | -126.45 |
Debt / Equity Ratio | -0.01 | -0.04 | -0.13 | -0.2 | -0.22 | -0.23 | -0.4 | 0.34 | 3.95 | 4.81 | 1.92 | 1.54 | 0.65 | 0.45 |
Quick Ratio | 0.33 | 0.38 | 0.33 | 0.44 | 0.60 | 0.47 | 0.75 | 1.17 | 0.56 | 0.45 | 0.78 | 1.91 | 2.88 | 4.79 |
Current Ratio | 0.55 | 0.56 | 0.46 | 0.57 | 0.76 | 0.59 | 0.85 | 1.33 | 0.64 | 0.56 | 0.82 | 2.27 | 3.18 | 4.97 |
Asset Turnover | 0.37 | 0.45 | 0.35 | 0.61 | 0.44 | 0.28 | 0.28 | 0.16 | 0.06 | 0.06 | 0.04 | 0.04 | 0.02 | 0.00 |
Interest Coverage | n/a | -14.9 | -13.29 | -11.73 | -13.78 | -16.69 | -15.92 | -7.56 | -13.85 | -17.86 | -22.38 | -15.79 | -16.77 | -17.59 |
Return on Equity | 0.54 | -0.12 | 0.27 | 0.06 | 0.31 | 0.38 | 2.39 | -3.52 | -3.57 | -4.29 | -2.52 | -1.57 | -0.72 | -0.49 |
Return on Assets | -0.79 | 0.10 | -0.44 | -0.07 | -0.3 | -0.26 | -0.93 | -1.19 | -0.37 | -0.4 | -0.59 | -0.46 | -0.34 | -0.29 |
Return on Invested Capital | 0.25 | 0.33 | 0.48 | 1.01 | 15.44 | 1.70 | -8.94 | -0.98 | -1.05 | -0.69 | -0.86 | -0.58 | -0.41 | -0.32 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.73 | 0.71 | 0.39 | 0.63 | 0.58 | 0.47 | 0.59 | 0.53 | -0.05 | 0.13 | -2.77 | -1.11 | 0.03 | -9.01 |
Net Profit Margin | -2.13 | 0.22 | -1.24 | -0.12 | -0.69 | -0.95 | -3.32 | -7.34 | -5.75 | -6.68 | -15.43 | -13.03 | -14.88 | -147.66 |
Pretax Profit Margin | -2.13 | 0.22 | -1.24 | -0.12 | -0.69 | -1.41 | -0.98 | -6.55 | -5.75 | -9.34 | -15.43 | -13.03 | -14.88 | -147.66 |
Operating Profit Margin | -0.49 | -0.48 | -1.12 | -0.6 | -0.93 | -1.76 | -1.72 | -2.53 | -5.36 | -8.84 | -14.77 | -12.26 | -14.05 | -139.84 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -0.49 | -0.46 | -1.09 | -0.05 | -0.61 | -1.28 | -1.71 | -2.44 | -1.76 | -7.72 | -14.39 | -11.83 | -13.58 | -135 |